相关实验视频

Updated: May 23, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

甲状腺下活动与帕金森病患者的积极抑制有关

Luna Damiani¹, Marion Albares¹, Pauline Laviron²

¹Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, Paris, France.

The European journal of neuroscience

|March 10, 2025

概括

在帕金森病 (PD) 患者中,多巴胺治疗和反应不确定性增加了亚thalamic核 (STN) 的低频活性,可能有助于抑制反应. 这与β带活动形成鲜明对比,这表明在调节行为方面具有互补作用.

科学领域:

神经科学是一个神经科学.
运动障碍运动障碍
神经生理学神经生理学

背景情况:

亚thalamic核 (STN) 在基底的间接途径中至关重要,其目标是通过深度大脑刺激 (DBS) 缓解帕金森病 (PD) 运动症状.
在PD中多巴胺耗尽增加了基底腺抑制输出,但STN在运动抑制中的确切作用尚不清楚.
了解STN在响应抑制中的功能对于完善PD治疗至关重要.

研究的目的:

研究STN局部现场潜力 (LFPs) 与在帕金森病患者不同不确定性期间的响应抑制之间的关系.
探索在STN中低频带 (LFB) 和β频带活动在修改的Go/NoGo任务中所扮演的不同角色.

主要方法:

对19名帕金森病患者进行了修改后的Go/NoGo任务,这些患者使用了STN-DBS植入物.
在任务期间记录了STN局部场势,特别注意低频带 (2-7 Hz) 和β频带 (12-30 Hz) 的功率.
任务参数操纵了关于响应执行或保留的不确定性.

主要成果:

多巴胺治疗显著增加了LFB功率,在响应不确定性期间进一步升高.
增加的LFB功率与更快的反应时间相关,这表明它在促进反应方面发挥了作用.
贝塔带功率呈现出反向模式,随着多巴胺治疗而下降,随着反应确定性而增加,与反应时间减慢相关.

结论:

低频STN活动可以补充beta频段活动来调节抑制控制,特别是在不确定的情况下.
STN LFB活动可以作为帕金森病中反应抑制调节的生物标志物.
这些发现提供了对PD运动控制和抑制背后的复杂神经机制的见解.

关键词:

基底性腺 (Basal Ganglia) 是一个多巴胺是多巴胺的一种.电力生理学电力生理学执行职能执行职能是指执行职能.发动机控制器的控制器

更多相关视频

Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

Published on: January 6, 2011

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.